Anti-S1/RBD-Specific Antibody Formation After SARS-CoV-2 Vaccination in Elderly Rheumatoid Arthritis Patients: Single-Center Prospective Observational Study.

Eun Song Kang Ji-Seon Oh Eun Ju Lee Seokchan Hong Soo Min Ahn Chang-Keun Lee Bin Yoo Yong-Gil Kim

Published in: Journal of Korean medical science (2023)

Our findings suggest that the third dose of the mRNA vaccine could be beneficial in RA patients with risk factors including older age, male sex, and corticosteroid use after two doses of ChAdOx1-S nCoV-19.

Keyphrases

rheumatoid arthritis patients
disease activity
sars cov
community dwelling
risk factors
middle aged
rheumatoid arthritis
systemic lupus erythematosus
ankylosing spondylitis
respiratory syndrome coronavirus
physical activity
binding protein
interstitial lung disease